JCO Global Oncology (Sep 2023)

Population-Level Access to Breast Cancer Early Detection and Diagnosis in Nigeria

  • Adeleye D. Omisore,
  • Elizabeth J. Sutton,
  • Racheal A. Akinola,
  • Anuoluwapo G. Towoju,
  • Adenike Akhigbe,
  • Uzoamaka R. Ebubedike,
  • Gavin Tansley,
  • Olalekan Olasehinde,
  • Amita Goyal,
  • Adedoyin Olabisi Akinde,
  • Olusegun I. Alatise,
  • Victoria Lee Mango,
  • T. Peter Kingham,
  • Gregory C. Knapp

DOI
https://doi.org/10.1200/GO.23.00093
Journal volume & issue
no. 9

Abstract

Read online

PURPOSEMammography, breast ultrasound (US), and US-guided breast biopsy are essential services for breast cancer early detection and diagnosis. This study undertook a comprehensive evaluation to determine population-level access to these services for breast cancer early detection and diagnosis in Nigeria using a previously validated geographic information system (GIS) model.METHODSA comprehensive list of public and private facilities offering mammography, breast US, and US-guided breast biopsy was compiled using publicly available facility data and a survey administered nationally to Nigerian radiologists. All facilities were geolocated. A cost-distance model using open-source population density (GeoData Institute) and road network data (OpenStreetMap) was used to estimate population-level travel time to the nearest facility for mammography, breast US, and US-guided biopsy using GIS software (ArcMAP).RESULTSIn total, 1,336 facilities in Nigeria provide breast US, of which 47.8% (639 of 1,336) are public facilities, and 218 provide mammography, of which 45.4% (99 of 218) are public facilities. Of the facilities that provide breast US, only 2.5% (33 of 1,336) also provide US-guided breast biopsy. At the national level, 83.1% have access to either US or mammography and 61.7% have access to US-guided breast biopsy within 120 minutes of a continuous one-way travel. There are differences in access to mammography (64.8% v 80.6% with access at 120 minutes) and US-guided breast biopsy (49.0% v 77.1% with access at 120 minutes) between the northern and southern Nigeria and between geopolitical zones.CONCLUSIONTo our knowledge, this is the first comprehensive evaluation of breast cancer detection and diagnostic services in Nigeria, which demonstrates geospatial inequalities in access to mammography and US-guided biopsy. Targeted investment is needed to improve access to these essential cancer care services in the northern region and the North East geopolitical zone.